DOI QR코드

DOI QR Code

$^{18}F$-FDG PET/CT in Primary AL Hepatic Amyloidosis Associated with Multiple Myeloma

  • Son, Youn-Mi (Department of Radiology, Seoul Medical Center) ;
  • Choi, Joon-Young (Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Bak, Cheol-Hee (Department of Radiology, Seoul Medical Center) ;
  • Cheon, Mi-Ju (Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Kim, Young-Eun (Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Lee, Kyung-Han (Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Kim, Byung-Tae (Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine)
  • Published : 2011.10.01

Abstract

We report here on a rare case of primary AL hepatic amyloidosis associated with multiple myeloma in a 64-year-old woman. The patient was referred for evaluating her progressive jaundice and right upper quadrant pain. $^{18}F$-fluorodeoxyglucose ($^{18}F$-FDG) positron emission tomography (PET)/computed tomography (CT) showed diffusely and markedly increased $^{18}F$-FDG uptake in the liver. Although there have been several case studies showing positive $^{18}F$-FDG uptake in pulmonary amyloidosis, to the best of our knowledge, the $^{18}F$-FDG PET/CT findings of hepatic amyloidosis or primary hepatic amyloidosis associated with multiple myeloma have not been reported previously.

Keywords

References

  1. Scott PP, Scott WW Jr, Siegelman SS. Amyloidosis: an overview. Semin Roentgenol 1986;21:103-112 https://doi.org/10.1016/0037-198X(86)90027-1
  2. Gertz MA, Kyle RA. Hepatic amyloidosis: clinical appraisal in 77 patients. Hepatology 1997;25:118-121 https://doi.org/10.1002/hep.510250122
  3. Yamamoto T, Maeda N, Kawasaki H. Hepatic failure in a case of multiple myeloma-associated amyloidosis (kappa-AL). J Gastroenterol 1995;30:393-397 https://doi.org/10.1007/BF02347517
  4. Okabe M, Choi GH, Kudo M, Nakaya H, Kishimoto A, Suzuki H, et al. Hepatic failure due to myeloma-associated amyloidosis. J Gastroenterol 1998;33:926-927 https://doi.org/10.1007/s005350050206
  5. Cross TJ, Wendon JA, Quaglia A, Salisbury JR, Heneghan MA, Harrison PM. Myeloma associated amyloidosis presenting as subacute liver failure. Postgrad Med J 2006;82:e13 https://doi.org/10.1136/pgmj.2006.044883
  6. Seo JH, Lee SW, Ahn BC, Lee J. Pulmonary amyloidosis mimicking multiple metastatic lesions on F-18 FDG PET/CT. Lung Cancer 2010;67:376-379 https://doi.org/10.1016/j.lungcan.2009.11.014
  7. Grubstein A, Shitrit D, Sapir EE, Cohen M, Kramer MR. Pulmonary amyloidosis: detection with PET-CT. Clin Nucl Med 2005;30:420-421 https://doi.org/10.1097/01.rlu.0000162965.38269.3c
  8. Kyle RA, Gertz MA. Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Semin Hematol 1995;32:45-59
  9. Vela-Ojeda J, Garcia-Ruiz Esparza MA, Padilla-Gonzalez Y, Sanchez-Cortes E, Garcia-Chavez J, Montiel-Cervantes L, et al. Multiple myeloma-associated amyloidosis is an independent high-risk prognostic factor. Ann Hematol 2009;88:59-66 https://doi.org/10.1007/s00277-008-0554-0
  10. Kim SH, Han JK, Lee KH, Won HJ, Kim KW, Kim JS, et al. Abdominal amyloidosis: spectrum of radiological findings. Clin Radiol 2003;58:610-620 https://doi.org/10.1016/S0009-9260(03)00142-9
  11. Urban BA, Fishman EK, Goldman SM, Scott WW Jr, Jones B, Humphrey RL, et al. CT evaluation of amyloidosis: spectrum of disease. Radiographics 1993;13:1295-1308
  12. Benson L, Hemmingsson A, Ericsson A, Jung B, Sperber G, Thuomas KA, et al. Magnetic resonance imaging in primary amyloidosis. Acta Radiol 1987;28:13-15 https://doi.org/10.3109/02841858709177299
  13. Ohta H, Endo K, Kanoh T, Konishi J, Kotoura H. Technetium- 99m (V) DMSA uptake in amyloidosis. J Nucl Med 1989;30:2049-2052
  14. Barai S, Bandopadhayaya GP, Rathi M, Singh NG. Accumulation of Tc99m-DMSA-3 in the spleen in a case of multiple myeloma with associated amyloidosis. J Postgrad Med 2005;51:119-121

Cited by

  1. 18F-FDG PET/CT in patients with amyloid light-chain amyloidosis: case-series and literature review vol.19, pp.2, 2012, https://doi.org/10.3109/13506129.2012.682833
  2. RE: Imaging Features of Hepato-Splenic Amyloidosis at PET/CT vol.13, pp.3, 2012, https://doi.org/10.3348/kjr.2012.13.3.368
  3. Utility of 18F-FDG PET(/CT) in patients with systemic and localized amyloidosis vol.40, pp.7, 2011, https://doi.org/10.1007/s00259-013-2375-1
  4. 18F-fluorodeoxyglucose positron emission tomography might be useful for diagnosis of hepatic amyloidosis vol.7, pp.None, 2011, https://doi.org/10.2147/imcrj.s63296
  5. PET-CT in Localized Oropharyngeal Amyloidosis : A Case Report and Literature Review vol.25, pp.2, 2011, https://doi.org/10.35420/jcohns.2014.25.2.276
  6. Diffuse Hepatic FDG Activity From Nonmalignant Etiologies vol.40, pp.7, 2011, https://doi.org/10.1097/rlu.0000000000000723
  7. Abdominal distension and diarrhea as the main symptoms of primary amyloidosis: A case report and literature review vol.11, pp.5, 2011, https://doi.org/10.3892/etm.2016.3093
  8. Suspected Pericardial Tuberculosis Revealed as an Amyloid Pericardial Mass vol.2018, pp.None, 2018, https://doi.org/10.1155/2018/8606430
  9. “Hepatic Superscan” in a Patient With Hepatosplenic Alphabeta T-cell Lymphoma: 18F-FDG PET/CT Findings vol.43, pp.8, 2011, https://doi.org/10.1097/rlu.0000000000002134
  10. Proposal for a Quantitative 18F-FDG PET/CT Metabolic Parameter to Assess the Intensity of Bone Involvement in Multiple Myeloma vol.9, pp.1, 2011, https://doi.org/10.1038/s41598-019-52740-2
  11. Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Amyloid Arthropathy Associated to Multiple Myeloma vol.26, pp.1, 2011, https://doi.org/10.1097/rhu.0000000000000768
  12. Amyloidosis Associated Kidney Failure with Gross Hypermetabolic Intra-abdominal Mass vol.29, pp.1, 2020, https://doi.org/10.4274/mirt.galenos.2019.92485